Heritage Investors Management Corp Boosts Stock Position in The Chemours Company (NYSE:CC)

Heritage Investors Management Corp lifted its position in shares of The Chemours Company (NYSE:CC) by 1.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 105,322 shares of the specialty chemicals company’s stock after purchasing an additional 1,174 shares during the period. Heritage Investors Management Corp’s holdings in Chemours were worth $1,780,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Blue Trust Inc. lifted its holdings in Chemours by 166.9% in the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 731 shares during the period. GAMMA Investing LLC lifted its holdings in Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 765 shares during the period. Truvestments Capital LLC purchased a new stake in Chemours in the third quarter worth about $35,000. Brooklyn Investment Group purchased a new position in shares of Chemours during the third quarter valued at approximately $37,000. Finally, Signaturefd LLC lifted its holdings in shares of Chemours by 163.7% during the third quarter. Signaturefd LLC now owns 1,959 shares of the specialty chemicals company’s stock valued at $40,000 after purchasing an additional 1,216 shares during the last quarter. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Chemours Trading Down 5.0 %

NYSE:CC opened at $15.19 on Friday. The company has a current ratio of 1.68, a quick ratio of 0.92 and a debt-to-equity ratio of 6.70. The Chemours Company has a 12 month low of $14.94 and a 12 month high of $29.21. The company has a market cap of $2.27 billion, a PE ratio of 26.66 and a beta of 1.81. The company has a 50 day simple moving average of $17.91 and a two-hundred day simple moving average of $18.84.

Chemours (NYSE:CC) last posted its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 6.58%. The ex-dividend date of this dividend is Friday, February 28th. Chemours’s dividend payout ratio (DPR) is presently 175.44%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CC. Morgan Stanley lowered their target price on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a report on Monday, January 13th. Royal Bank of Canada reiterated an “outperform” rating and set a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Mizuho lowered their target price on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating for the company in a report on Tuesday, January 7th. Barclays reduced their price target on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday. Finally, The Goldman Sachs Group reduced their price target on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $23.11.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.